UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

Value in health, 2012-12, Vol.15 (8), p.1162-1171

2012

Link zum Volltext

Verfügbarkeit prüfen

Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib

Value in health, 2011-09, Vol.14 (6), p.846-851

2011

Link zum Volltext

Verfügbarkeit prüfen

HOUT-18. COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi116-vi117

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-257: Tumor treating fields treatment for patients with newly diagnosed glioblastoma: A cost-effectiveness analysis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-257-LB-257

2018

Link zum Volltext

Verfügbarkeit prüfen

Sustainability of Universal Health Coverage: Five Continents, Four Perspectives

Value in health, 2013, Vol.16

GARRISON, Lou

2013

Link zum Volltext

Verfügbarkeit prüfen

HOUT-16. THE COST EFFECTIVENESS OF TUMOR TREATING FIELDS TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA BASED ON THE EF-14 TRIAL

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi116-vi116

2018

Link zum Volltext

Verfügbarkeit prüfen

495 - Estimating the Current and Future Costs and Health Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HCT)

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S371-S371

2023

Link zum Volltext

Verfügbarkeit prüfen

Estimating the Current and Future Costs and Health Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HCT)

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S371

2023

Link zum Volltext

Verfügbarkeit prüfen

Extending the reach of public health genomics: What should be the agenda for public health in an era of genome-based and “personalized” medicine?

Genetics in medicine, 2010-12, Vol.12 (12), p.785-791

2010

Link zum Volltext

Verfügbarkeit prüfen

What principles should govern the use of managed entry agreements?

International journal of technology assessment in health care, 2011-01, Vol.27 (1), p.77-83

2011

Link zum Volltext

Verfügbarkeit prüfen

The Drug Budget Silo Mentality in Europe: An Overview

Value in health, 2003-07, Vol.6 (s1), p.S1-S9

2003

Link zum Volltext

Verfügbarkeit prüfen

HOUT-18. COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi116-vi117

2018

Link zum Volltext

Verfügbarkeit prüfen

A CORRELATIONAL STUDY OF FACTORS UTILIZED IN COUNSELOR CANDIDATE SELECTION AT WESTERN MICHIGAN UNIVERSITY

GARRISON, MARY LOU

1967

Link zum Volltext
ProQuest

Isolation of scFvs to in vitro produced extracellular domains of EGFR family members

Cancer biotherapy & radiopharmaceuticals, 2005-12, Vol.20 (6), p.603-613

2005

Link zum Volltext

Verfügbarkeit prüfen

Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay

AIDS research and human retroviruses, 1990-11, Vol.6 (11), p.1251-1256

1990

Link zum Volltext

Verfügbarkeit prüfen

Retention of Homeless Clients in Substance Abuse Treatment: Findings From the National Institute on Alcohol Abuse and Alcoholism Cooperative Agreement Program

Journal of substance abuse treatment, 1999-07, Vol.17 (1), p.45-66

1999

Link zum Volltext

Verfügbarkeit prüfen

Retention of Homeless Clients in Substance Abuse Treatment

Journal of substance abuse treatment, 1999-07, Vol.17 (1-2), p.45-66

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(16)

Publikationsform

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib

HOUT-18. COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE

Abstract LB-257: Tumor treating fields treatment for patients with newly diagnosed glioblastoma: A cost-effectiveness analysis

Sustainability of Universal Health Coverage: Five Continents, Four Perspectives

HOUT-16. THE COST EFFECTIVENESS OF TUMOR TREATING FIELDS TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA BASED ON THE EF-14 TRIAL

495 - Estimating the Current and Future Costs and Health Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HCT)

Estimating the Current and Future Costs and Health Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HCT)

Extending the reach of public health genomics: What should be the agenda for public health in an era of genome-based and “personalized” medicine?

What principles should govern the use of managed entry agreements?

The Drug Budget Silo Mentality in Europe: An Overview

HOUT-18. COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE

A CORRELATIONAL STUDY OF FACTORS UTILIZED IN COUNSELOR CANDIDATE SELECTION AT WESTERN MICHIGAN UNIVERSITY

Isolation of scFvs to in vitro produced extracellular domains of EGFR family members

Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay

Retention of Homeless Clients in Substance Abuse Treatment: Findings From the National Institute on Alcohol Abuse and Alcoholism Cooperative Agreement Program

Retention of Homeless Clients in Substance Abuse Treatment

Suchergebnisse filtern